| [1] |
Katryna Cisek, Grace L Cooper, Carol J Huseby, and Jeff Kuret
"Structure and mechanism of action of tau aggregation inhibitors."
Curr Alzheimer Res 11, 918-27 (2014).
|
| [2] |
Kelsey N Schafer, Katryna Cisek, Carol J Huseby, Edward Chang, and Jeff Kuret
"Structural determinants of tau aggregation inhibitor potency."
J. Biol. Chem. 288, 32599-611 (2013).
|
| [3] |
Katryna Cisek and Jeff Kuret
"QSAR studies for prediction of cross-β sheet aggregate binding affinity and selectivity."
Bioorg. Med. Chem. 20, 1434-41 (2012).
|
| [4] |
Katryna Cisek, Jordan R Jensen, Nicolette S Honson, Kelsey N Schafer, Grace L Cooper, and Jeff Kuret
"Ligand electronic properties modulate tau filament binding site density."
Biophys. Chem. 170, 25-33 (2012).
|
| [5] |
Jordan R Jensen, Katryna Cisek, Nicolette S Honson, and Jeff Kuret
"Ligand polarizability contributes to tau fibril binding affinity."
Bioorg. Med. Chem. 19, 5147-54 (2011).
|
| [6] |
Kelsey N Schafer, Dhiraj P Murale, Kibong Kim, Katryna Cisek, Jeff Kuret, and David G Churchill
"Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors."
Bioorg. Med. Chem. Lett. 21, 3273-6 (2011).
|
| [7] |
Jordan R Jensen, Katryna Cisek, Kristen E Funk, Swati Naphade, Kelsey N Schafer, and Jeff Kuret
"Research towards tau imaging."
J. Alzheimers Dis. 26, 147-57 (2011).
|
| [8] |
B Fuh, M Sobo, L Cen, D Josiah, B Hutzen, K Cisek, D Bhasin, N Regan, L Lin, C Chan, H Caldas, S DeAngelis, C Li, P-K Li, and J Lin
"LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model."
Br. J. Cancer 100, 106-12 (2009).
|
| [9] |
Deepak Bhasin, Katryna Cisek, Trupti Pandharkar, Nicholas Regan, Chenglong Li, Bulbul Pandit, Jiayuh Lin, and Pui-Kai Li
"Design, synthesis, and studies of small molecule STAT3 inhibitors."
Bioorg. Med. Chem. Lett. 18, 391-5 (2008).
|
